Millennium Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Buy
+4,000
New +$2.05M ﹤0.01% 3910
2025
Q4
Sell
-400
Closed -$206K 6282
2025
Q3
$206K Buy
+400
New +$175K ﹤0.01% 5534
2024
Q4
Sell
-23,100
Closed -$7.71M 6242
2024
Q3
$7.71M Buy
+23,100
New +$8.78M ﹤0.01% 2432
2024
Q2
Sell
-23,500
Closed -$9.5M 6284
2024
Q1
$9.5M Buy
+23,500
New +$8.26M ﹤0.01% 2240
2019
Q3
Sell
-50,000
Closed -$3.27M 4399
2019
Q2
$3.27M Buy
+50,000
New +$2.88M ﹤0.01% 2100

Other funds holding MEDP

Millennium Management's MEDP Position: Q1 2026 in Review

Millennium Management reduced its Medpace (MEDP) stake by 89% in Q1 2026, selling an estimated $23.7M and leaving 5,676 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3570.

Millennium Management first reported a position in MEDP in Q3 2016 and has held it in 34 quarters since. The position peaked at $108M in Q2 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Millennium Management held 5,676 shares of Medpace worth $2.73M as of Q1 2026.
  • Millennium Management sold 46,315 Medpace shares in Q1 2026, an estimated $23.7M.
  • Medpace made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3570 holding.
  • Millennium Management first reported a position in Medpace in Q3 2016 and has held it in 34 quarters since.
  • Millennium Management's Medpace position peaked at $108M in Q2 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.